30 related articles for article (PubMed ID: 33367933)
1. Patient-Derived Xenografts: A Valuable Preclinical Model for Drug Development and Biomarker Discovery.
Weng T; Jenkins BJ; Saad MI
Methods Mol Biol; 2024; 2806():19-30. PubMed ID: 38676793
[TBL] [Abstract][Full Text] [Related]
2. Stratification of pancreatic tissue samples for molecular studies: RNA-based cellular annotation procedure.
Heller A; Gaida MM; Männle D; Giese T; Scarpa A; Neoptolemos JP; Hackert T; Strobel O; Hoheisel JD; Giese NA; Bauer AS
Pancreatology; 2015; 15(4):423-31. PubMed ID: 26118650
[TBL] [Abstract][Full Text] [Related]
3. The Prognostic Impact of Eosinophils and the Eosinophil-to-Lymphocyte Ratio on Survival Outcomes in Stage II Resectable Pancreatic Cancer.
Ohkuma R; Kubota Y; Horiike A; Ishiguro T; Hirasawa Y; Ariizumi H; Watanabe M; Onoue R; Ando K; Tsurutani J; Yoshimura K; Aoki T; Murakami M; Kobayashi S; Tsunoda T; Wada S
Pancreas; 2021 Feb; 50(2):167-175. PubMed ID: 33565793
[TBL] [Abstract][Full Text] [Related]
4. System analysis based on the lysosome-related genes identifies HPS4 as a novel therapy target for liver hepatocellular carcinoma.
He KJ; Nie Z
Front Oncol; 2023; 13():1221498. PubMed ID: 37781184
[TBL] [Abstract][Full Text] [Related]
5. Human epididymis protein 4 (HE4) is a novel biomarker for fibrosis in IgG4-related disease and can predict poor prognosis.
Yan S; Peng Y; Wu Z; Lu H; Mo S; Chen X; Huang Y; Li X; Zhang W; Li Y
RMD Open; 2022 Sep; 8(2):. PubMed ID: 36167476
[TBL] [Abstract][Full Text] [Related]
6. Serum biomarker panel diagnostics in pancreatic ductal adenocarcinoma: the clinical utility of soluble interleukins, IFN-γ, TNF-α and PD-1/PD-L1 in comparison to established serum tumor markers.
Dorman K; Gerckens M; Kruger S; Krueger K; Mayer Z; Rupp A; Zhang D; Weiss L; Westphalen CB; Haas M; Guenther M; Ormanns S; Klawonn F; Werner J; von Bergwelt-Baildon M; Heinemann V; Boeck S; Holdenrieder S
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2463-2474. PubMed ID: 35737090
[TBL] [Abstract][Full Text] [Related]
7. Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer?
El Bairi K; Afqir S; Amrani M
Curr Drug Targets; 2020; 21(10):1026-1033. PubMed ID: 32334501
[TBL] [Abstract][Full Text] [Related]
8. HE4 tumor marker as a predictive factor for lymphatic metastasis in endometrial cancer.
Espiau Romera A; Cuesta Guardiola T; Benito Vielba M; De Bonrostro Torralba C; Coronado Martín PJ; Baquedano Mainar L
Int J Gynaecol Obstet; 2020 Jun; 149(3):265-268. PubMed ID: 32147821
[TBL] [Abstract][Full Text] [Related]
9. High expression levels of polymeric immunoglobulin receptor are correlated with chemoresistance and poor prognosis in pancreatic cancer.
Ohkuma R; Yada E; Ishikawa S; Komura D; Kubota Y; Hamada K; Horiike A; Ishiguro T; Hirasawa Y; Ariizumi H; Shida M; Watanabe M; Onoue R; Ando K; Tsurutani J; Yoshimura K; Sasada T; Aoki T; Murakami M; Norose T; Ohike N; Takimoto M; Kobayashi S; Tsunoda T; Wada S
Oncol Rep; 2020 Jul; 44(1):252-262. PubMed ID: 32627041
[TBL] [Abstract][Full Text] [Related]
10. High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer.
Ohkuma R; Yada E; Ishikawa S; Komura D; Ishizaki H; Tamada K; Kubota Y; Hamada K; Ishida H; Hirasawa Y; Ariizumi H; Satoh E; Shida M; Watanabe M; Onoue R; Ando K; Tsurutani J; Yoshimura K; Yokobori T; Sasada T; Aoki T; Murakami M; Norose T; Ohike N; Takimoto M; Izumizaki M; Kobayashi S; Tsunoda T; Wada S
PLoS One; 2020; 15(1):e0226707. PubMed ID: 31923206
[TBL] [Abstract][Full Text] [Related]
11. MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer.
Xu H; Zou R; Li F; Liu J; Luan N; Wang S; Zhu L
Cancer Med; 2021 Jun; 10(11):3655-3673. PubMed ID: 33934540
[TBL] [Abstract][Full Text] [Related]
12. Human epididymis protein 4 promotes P‑glycoprotein‑mediated chemoresistance in ovarian cancer cells through interactions with Annexin II.
Liu Q; Liu DW; Zheng MJ; Deng L; Wang HM; Jin S; Liu JJ; Hao YY; Zhu LC; Lin B
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33955501
[TBL] [Abstract][Full Text] [Related]
13. Role of human epididymis protein 4 in chemoresistance and prognosis of epithelial ovarian cancer.
Lee S; Choi S; Lee Y; Chung D; Hong S; Park N
J Obstet Gynaecol Res; 2017 Jan; 43(1):220-227. PubMed ID: 27862665
[TBL] [Abstract][Full Text] [Related]
14. High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor prognosis in pancreatic cancer.
Ohkuma R; Yada E; Ishikawa S; Komura D; Kubota Y; Hamada K; Horiike A; Ishiguro T; Hirasawa Y; Ariizumi H; Shida M; Watanabe M; Onoue R; Ando K; Tsurutani J; Yoshimura K; Sasada T; Aoki T; Murakami M; Norose T; Ohike N; Takimoto M; Kobayashi S; Tsunoda T; Wada S
Int J Oncol; 2021 Jan; 58(1):57-69. PubMed ID: 33367933
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
